SONOLUCENT CRANIAL RECONSTRUCTION DEVICE
A sonolucent cranial reconstruction device is optimized for trans-cranioplasty ultrasound. The cranial reconstruction device includes a tubular base member and a sonolucent upper wall extending across the top of the tubular base member. The tubular base member is shaped and dimensioned for positioning within an aperture defined by a cranial defect such that bone growth is prevented within the aperture defined by the cranial defect.
1 . A sonolucent cranial reconstruction device optimized for trans-cranioplasty ultrasound, comprising:
a tubular base member and a sonolucent upper wall extending across a top of the tubular base member, the tubular base member being shaped and dimensioned for positioning within an aperture defined by a cranial defect such that bone growth is prevented within the aperture defined by the cranial defect.
2 . The sonolucent cranial reconstruction device according to claim 1 , wherein the tubular base member extends a thickness of a cranium to mechanically prevent bone remodeling in the cranial defect, thereby preserving acoustic pass-through.
3 . The sonolucent cranial reconstruction device according to claim 1 , wherein the tubular base member is formed with a cross sectional profile selected from the group consisting of cylindrical, square, rectangular, oval, and polyhedral.
4 . The sonolucent cranial reconstruction device according to claim 1 , wherein the tubular base member includes an annular frame member defining an outer perimeter of the tubular base member, the annular frame member includes an upper surface, a lower surface, an inner sidewall extending between the upper surface and the lower surface along a cavity defined by an interior of the annular frame member, and an outer sidewall extending between the upper surface and the lower surface of the annular frame member.
5 . The sonolucent cranial reconstruction device according to claim 4 , wherein the inner sidewall and the outer sidewall define consistent and continuous diameters.
6 . The sonolucent cranial reconstruction device according to claim 4 , wherein the tubular base member is 7 mm to 9 mm from the upper surface to the lower surface.
7 . The sonolucent cranial reconstruction device according to claim 4 , wherein the sonolucent upper wall is coextensive with the upper surface of the annular frame member such that the sonolucent upper wall and the inner sidewall define a cavity of the cranial reconstruction device.
8 . The sonolucent cranial reconstruction device according to claim 4 , wherein a thickness of the sonolucent upper wall is less than a length of the tubular base member, thus forming the cavity defining an open area inside the tubular base member.
9 . The sonolucent cranial reconstruction device according to claim 8 , wherein a space defined by the cavity is filled with a highly ultrasound transmissive fluid, gel, or other material to enhance or otherwise control passage of ultrasound waves through the cranial reconstruction device.
10 . The sonolucent cranial reconstruction device according to claim 8 , wherein a lensing window is integrated into the cavity of the tubular base member to manipulate or alter ultrasound wave.
11 . The sonolucent cranial reconstruction device according to claim 1 , wherein the sonolucent upper wall includes an upper surface, a lower surface, and a sidewall extending between the upper surface and the lower surface.
12 . The sonolucent cranial reconstruction device according to claim 11 , wherein the sidewall of the sonolucent upper wall is tapered inwardly along a lower portion thereof such that a diameter of the sidewall decreases as it extends from the upper surface toward the lower surface of the sonolucent upper wall.
13 . The sonolucent cranial reconstruction device according to claim 11 , wherein the sonolucent upper wall is further provided with outwardly extending tab members coextensive with the sonolucent upper wall.
14 . The sonolucent cranial reconstruction device according to claim 1 , wherein the tubular base member and the sonolucent upper wall are integrally formed.
15 . The sonolucent cranial reconstruction device according to claim 14 , wherein the tubular base member and the sonolucent upper wall are manufactured from sonolucent poly (methyl methacrylate) (PMMA).
16 . The sonolucent cranial reconstruction device according to claim 1 , wherein the sonolucent upper wall and the tubular base member are distinct pieces that are selectively assembled and/or disassembled.
17 . The sonolucent cranial reconstruction device according to claim 16 , wherein the tubular base member and the sonolucent upper wall are formed from different materials offering optimal physical characteristics for their intended purposes.
18 . The sonolucent cranial reconstruction device according to claim 17 , wherein the tubular base member is made of porous polyethylene.
19 . The sonolucent cranial reconstruction device according to claim 17 , wherein the sonolucent upper wall is made of PMMA.
20 . The sonolucent cranial reconstruction device according to claim 1 , further including an ultrasound transducer.
21 . A method for preventing bone growth within a cranial defect, comprising:
forming a cranial defect;
implanting a cranial reconstruction device within the cranial defect such that the cranial reconstruction device covers the entire internal surface of the cranial defect.
22 . The method according to claim 21 , wherein the cranial reconstruction device is sonolucent.
23 . The method according to claim 22 , further including a step of passing ultrasound through the cranial reconstruction device.
24 . The method according to claim 22 , wherein the cranial reconstruction device includes a tubular base member and a sonolucent upper wall extending across a top of the tubular base member.
25 . The method according to claim 22 , further including a step of acting upon and/or monitoring a contrast agent as it travels within the brain.
26 . The method according to claim 25 , further including a step of imaging confirmation of blood flow immediately after surgery, imaging confirmation of blood flow during follow-up examinations, imaging confirmation of blood flow to desired locations within the brain, imaging visualization of, and guidance during, interventional procedures to guide a wire and/or catheter, or activating a contrast agent as it passes a particular point of interest and is subjected to ultrasound for activation thereof.
27 . The method according to claim 22 , further including a step of utilizing ultrasound in conjunction with drug delivery.
28 . The method according to claim 27 , further including a step of subjecting a drug to ultrasound at a specific location within the brain so that the drug is active at a highly specific location, subjecting a drug to ultrasound at a specific location within the brain to enhance effectiveness of the drug through delivery of ultrasound, subjecting the drug to ultrasound at a specific location within the brain to assist the drug in passing through the brain blood barrier, or therapeutically releasing nano-encapsulated drugs through the application of ultrasound wherein the ultrasound breaks down the encapsulation material to release the drug.